TAP Consulting’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.46M | Buy |
|
|||||
|
2024
Q3 | $3.02M | Buy |
|
|||||
|
2024
Q2 | $2.53M | Sell |
|
|||||
|
2024
Q1 | $3.1M | Buy |
|
|||||
|
2023
Q4 | $2.29M | Sell |
|
|||||
|
2023
Q3 | $2.47M | Sell |
|
|||||
|
2023
Q2 | $3.18M | Sell |
|
|||||
|
2023
Q1 | $3.4M | Sell |
|
|||||
|
2022
Q4 | $2.78M | Sell |
|
|||||
|
2022
Q3 | $3.18M | Buy |
|
|||||
|
2022
Q2 | $3.68M | Sell |
|
|||||
|
2022
Q1 | $6.81M | Buy |
|
|||||
|
2021
Q4 | $7.06M | Buy |
|
|||||
|
2021
Q3 | $6.11M | Sell |
|
|||||
|
2021
Q2 | $5.5M | Buy |
|
|||||
|
2021
Q1 | $4.24M | Buy |
|
|||||
|
2020
Q4 | $4.21M | Sell |
|
|||||
|
2020
Q3 | $4.53M | Sell |
|
|||||
|
2020
Q2 | $4.2M | Sell |
|
|||||
|
2020
Q1 | $3.13M | Buy |
|
|||||
|
2019
Q4 | $2.93M | Buy |
|
|||||
|
2019
Q3 | $2.54M | Buy |
|
|||||
|
2019
Q1 | $1.87M | Buy |
|